Skip to main content

Advertisement

ADVERTISEMENT

Editor's Message

Editor's 2023 Top 10

Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI

Video file
Dr Deepak L. Bhatt, Editor-in-Chief of JIC, presents the Top 10 articles from 2023.

 

2023 Top 10 Articles

Delayed Pericardial Effusion Following Left Atrial Appendage Closure: A 5-Year Single-Center Experience

Akhil Mogalapalli, MD; Sundeep Kumar, MD; Tabitha Lobo, MD; Joseph Reed, MD; Luis Augusto Palma Dallan, MD, PhD;  Sung-Han Yoon, MD;  Steven J. Filby, MD

J INVASIVE CARDIOL 2023;35(1):E1-E6.

Watch the accompanying author interview here.


Utilization Trends and Short-Term Outcomes for Transcatheter and Surgical Aortic Valve Replacement Surgery in New York

Feng Qian, MD, PhD, MBA; Zaza Samadashvili, MD, MPH, MA; Edward L. Hannan, PhD, MS

J INVASIVE CARDIOL 2023;35(1):E7-E16.


Short-Term Outcomes After Retrograde Versus Antegrade Crossing Approaches for Femoropopliteal Occlusive Disease

Steven Meadors, MD;  Andrea Klein, MD;  Haekyung Jeon-Slaughter, PhD; Omar Jawaid, MD;  Ehrin J. Armstrong, MD;  Rahul Banerjee;  Mohamad Amer Alaiti, MD;  Bala Ramanan, MBBS;  J. Gregory Modrall, MD;  Subhash Banerjee, MD;  Shirling Tsai, MD

J INVASIVE CARDIOL 2023;35(1):E31-E36.

Watch the accompanying author interview here.


Equipment Utilization in Chronic Total Occlusion Percutaneous Coronary Interventions: Update From the PROGRESS-CTO Registry

Spyridon Kostantinis, MD;  Bahadir Simsek, MD;  Judit Karacsonyi, MD, PhD; Athanasios Rempakos, MD;  Khaldoon Alaswad, MD;  Farouc A. Jaffer, MD, PhD;  Jaikirshan J. Khatri, MD;  Paul Poommipanit, MD;  Rhian E. Davies, DO; Stephane Rinfret, MD;  William Nicholson, MD;  Wissam Jaber, MD;  James W. Choi, MD;  Mitul P. Patel, MD;  Michael Koutouzis, MD; Ioannis Tsiafoutis, MD;  Sevket Gorgulu, MD;  Taral N. Patel, MD;  Brian K. Jefferson, MD;  Jimmy L. Kerrigan, MD;  Basem Elbarouni, MD;  Nidal Abi Rafeh, MD; Omer Goktekin, MD;  Ahmed M. ElGuindy, MD;  Salman Allana, MD;  Olga C. Mastrodemos, BA;  Bavana V. Rangan, BDS, MPH; Yader Sandoval, MD;  M. Nicholas Burke, MD;  Emmanouil S. Brilakis, MD, PhD

J INVASIVE CARDIOL 2023;35(2):E61-E69.

Watch the accompanying author interview here.


Efficacy and Safety of an Upfront RotaTripsy Strategy in the Treatment of De Novo and In-Stent Restenosis Cases

Prashant Dwivedi, MD;  Vishal Dhulipala, MD;  Kartik R. Kumar, MD;  Anoop N. Koshy, MBBS, PhD;  Keisuke Yasumura, MD;  Amit Hooda, MD;  Raman Sharma, MD;  George Dangas, MD, PhD;  Annapoorna S. Kini, MD;  Samin K. Sharma, MD

J INVASIVE CARDIOL 2023;35(2):E70-E74.


A Procedural Guide for Implanting the Cordella Pulmonary Artery Pressure Sensor

Jason L. Guichard, MD, PhD;  Faisal Sharif, MD;  Omid Forouzan, PhD;  Jerson Martina, PhD;  Liviu Klein, MD

J INVASIVE CARDIOL 2023;35(2):E75-E83.


Efficacy of Transpedal Retrograde Approach in Endovascular Treatment of Patients With Buerger’s Disease

Ersan Tatli, MD; Ali Buturak, MD; Mehmet Bülent Vatan, MD; Imran Kurt Ömürlü, MD; Alper Erkin, MD

J INVASIVE CARDIOL 2023;35(2):E84-E91.


Percutaneous Coronary Intervention and Stenting for the Treatment of Myocardial Muscle Bridges: A Consecutive Case Series

Ahmed Abdalwahab, MSc;  Mina Ghobrial, MBBS, MRCP;  Mohamed Farag, MSc, PhD;  Tarik Salim, MD;  Gregg W. Stone, MD;  Mohaned Egred, MBChB, MD

J INVASIVE CARDIOL 2023;35(4):E169-E178.


Update on Chronic Total Occlusion Percutaneous Coronary Intervention

Athanasios Rempakos, MD;  Spyridon Kostantinis, MD;  Bahadir Simsek, MD; Judit Karacsonyi, MD, PhD;  Masahisa Yamane, MD;  Khaldoon Alaswad, MD; Mir Basir, MD;  Rhian Davies, DO;  Stewart M. Benton, Jr, MD;  James Choi, MD;  Sevket Gorgulu, MD;  Jaikirshan J. Khatri, MD;  William Nicholson, MD; Stephane Rinfret, MD;  Wissam Jaber, MD;  Mohaned Egred, MD;  Anastasios Milkas, MD;  Bavana V. Rangan, BDS, MPH;  Olga C. Mastrodemos, BA;  Yader Sandoval, MD;  Salman Allana, MD;  M. Nicholas Burke, MD;  Emmanouil S. Brilakis, MD, PhD

J INVASIVE CARDIOL 2023;35(4):E194-E204.

Watch the accompanying author interview here.


Serial Assessment of Coronary Artery Healing of a Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months by Optical Coherence Tomography (OCT)—The REPAIR Trial

Guilherme Barreto Gameiro Silva, MD;  Rafael A. Meneguz-Moreno, MD, PhD; Ricardo Costa, MD, PhD;  Daniel Chamié, MD, PhD;  George Dangas, MD, PhD;  André Manica, MD, PhD;  Jose Airton Arruda, MD, PhD;  Amanda G.M.R. Sousa, MD, PhD;  Fausto Feres, MD, PhD;  J. Ribamar Costa, Jr, MD, PhD

J INVASIVE CARDIOL 2023;35(5):E225-E233.

Watch the accompanying author interview here.



Transcript:

Hello, I'm Dr. Deepak Bhatt, Editor-in-Chief of the Journal of Invasive Cardiology. We've compiled a Top 10 list of the top 10 most popular articles from the Journal of Invasive Cardiology for 2023. Over the next few weeks, we will be catching up with the authors of these papers to get their own insights on their study, hear about any updates, and see what they have planned for future research. I'm going to go through these articles now, just highlighting a few points about them; and they're not in any particular order other than chronological order in terms of when they were published in 2023.

00:41: The first is Delayed Pericardial Effusion Following Left Atrial Appendage Closure: A 5-Year Single-Center Experience, and this, I think, is a very interesting analysis of 369 patients who underwent left atrial appendage closure at the Cleveland Medical Center. The authors compared patients who developed effusion to patients who did not to determine if there was any factor that might predispose them to developing acute or delayed pericardial effusion. It was, I think, very insightful given the large number of left atrial appendage closures that are starting to occur.

01:20: The next article on our list is Utilization Trends and Short-Term Outcomes for Transcatheter and Surgical Aortic Valve Replacement Surgery in New York. And this was examining the New York State data to see how TAVR (transcatheter aortic valve replacement) and surgical aortic valve replacement were faring in terms of this statewide registry over the course of 30 days examining post-operative mortality, and what they found was that TAVR, in particular, has experienced massive growth, whereas surgical aortic valve replacement has decreased. So, interesting data in terms of what's going on with TAVR and SAVR, and changes in mortality as well - TAVR was associated with continuous improvement in the 30-day postop mortality.

02:11: The next article is Short-Term Outcomes After Retrograde Versus Antegrade Crossing Approaches for Femoropopliteal Occlusive Disease. This is a really nice analysis from the XLPAD registry, examining femoropopliteal occlusive disease and treatments, using antegrade vs retrograde crossing. So especially for folks that are interested in advanced techniques and peripheral intervention. Very useful article.

02:44: The next article is Equipment Utilization in Chronic Total Occlusion Percutaneous Coronary Interventions: Update From the PROGRESS-CTO Registry. And this, I think, is useful information for operators that are interested in doing CTOs that want to start, that are doing them, talks about the most commonly used equipment. So it gives you a sense of what equipment might be useful if you're starting to do these, or even if you have been doing them for a while, what these folks thought the latest and best equipment might be.

03:14: The next article is Efficacy and Safety of an Upfront RotaTripsy Strategy in the Treatment of De Novo and In-Stent Restenosis Cases. Actually, this is from the Mount Sinai Cath Lab, but it was before I joined the Cath Lab. I thought, very interesting paper looking at a strategy of combining the rotablation with the lithotopripsy. See, these are both great ways to tackle calcium, but combining them both together potentially in certain types of lesions can be extremely useful. So great data, I thought, and for folks that are dealing with calcified lesions, which is most cath labs these days, it can be really useful to be familiar with these techniques.

04:14: The next article I'm going to mention is A Procedural Guide for Implanting the Cordella Pulmonary Artery Pressure Sensor. It's basically a nice summary of how to do the procedure, and then a case series with some details of some actual patients getting it. So if you're going to start using this particular type of sensor for measuring PA pressures, this would be a great way to get started.

04:41: The next article is Efficacy of Transpedal Retrograde Approach in Endovascular Treatment of Patients With Buerger’s Disease. This is something that all of us in the world of vascular medicine learn about or are on the lookout for. But we don't see all that much in the US these days. This is from Turkey, where this particular case series of 18 patients originates from, and I think it's a useful article to have in your toolbox of approaches, for how to treat complex peripheral artery disease, especially things that we may not see as commonly, such as Burger's disease.

05:19: The next article is Percutaneous Coronary Intervention and Stenting for the Treatment of Myocardial Muscle Bridges: A Consecutive Case Series. I think this is extremely useful. Most of the time we don't want to stent myocardial bridges, but every now and then there's true ischemia and a true need to do it. And this article details nicely just how to do it, what the outcomes were, and so forth. Actually, I interviewed Dr Greg Stone, who is one of the co-authors on this article last year, as part of the Journal of Invasive Cardiology interview series. So we'll interview one of the other authors later on this year to get that author's perspective. But this, again, is a nice thing to have in your toolbox just to know if this comes up, and it's pretty rare. But if it comes up just time to deal with a myocardial bridge percutaneously.

06:11: The next article is Update on Chronic Total Occlusion Percutaneous Coronary Intervention. This is a very nice update on CTO PCI, especially focusing on some of the more recent advances in treating right total occlusion. So, it may be worth your while to take a look if you're doing CTO for trying to wrap up efforts in CTO intervention.

6:36: And the final article of the year - and again, these were just in chronological order, as far as our top 10 go - was Serial Assessment of Coronary Artery Healing of a Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months by Optical Coherence Tomography (OCT)—The REPAIR Trial. So I think this is some nice imaging data showing just how coronary arteries heal after biodegradable polymer drug-eluting stents. So useful just to see on the inside what's going on when we implant stents.

So, a variety of different studies spanning coronary artery disease, intravascular imaging, complex coronary intervention, peripheral intervention, structural heart disease, reflecting the wide variety of article types that we solicit and publish in the Journal of Invasive Cardiology. It really is meant to be a resource for doctors and other healthcare professionals involved in caring for patients that are entering the interventional cath suite. And we cover things including diagnostic procedures, as well as intervention of course, and even though none of them made the Top 10 list, it isn't just interventional cardiology or diagnostic cardiac catheterizations that we cover, we also do cover electrophysiology, especially when it pertains to common sorts of procedures, and we also do cover pediatric and congenital interventions. So really, the wide range of invasive cardiology – that’s why it’s the Journal of Invasive Cardiology –  it’s meant to span all those different disciplines.

Well, hopefully, this review of the top 10 from JIC from last year is piqued your interest, and you will go and visit our website and look at some of these articles and others. Thank you very much for your attention.

© 2024 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the Journal of Invasive Cardiology or HMP Global, their employees, and affiliates. 

 


Advertisement

Advertisement

Advertisement